Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | PRKCA | P17252 | 1/20 | 0.35 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.35 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 4/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 5/20 | 0.34 |
| ▸ | CA1 | P00915 | 3/20 | 0.34 |
| ▸ | CTSK | P43235 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4730323 | 0.93 | OPRM1 (0.37) | DNM1TSHR | |
| SCHEMBL10672112 | 0.81 | ALDH1A1 (0.38) | ALDH1A1TDP1PRKCAPRKCDDNM1 | |
| SCHEMBL4169871 | 0.78 | — | — | |
| SCHEMBL887651 | 0.76 | ALDH1A1 (0.40) | ALDH1A1TDP1PRKCAPRKCDDNM1 | |
| SCHEMBL10533388 | 0.75 | LMNA (0.37) | PRKCAPRKCDCA1 | |
| Magnesium SCHEMBL10632211 | 0.74 | ALDH1A1 (0.39) | ALDH1A1TDP1PRKCAPRKCDDNM1 | |
| SCHEMBL10642096 | 0.74 | — | — | |
| SCHEMBL19060744 | 0.72 | ALDH1A1 (0.37) | ALDH1A1TDP1PRKCAPRKCDDNM1 | |
| SCHEMBL10642093 | 0.72 | — | — | |
| SCHEMBL14565671 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090110842-A1 | Boron-based wood preservatives and treatment of wood with boron-based preservatives | THE UNIVERSITY OF MELBOUME (AU) | 2009-04-30 | — | — | US | disclosed |
| US-20090069271-A1 | WOOD TREATMENT | STANIMIROFF IVAN LAURENCE | 2009-03-12 | — | — | US | disclosed |
| EP-1945424-A1 | WOOD TREATMENT | Stanimiroff, Ivan Laurence (NZ) | 2008-07-23 | — | — | EP | disclosed |
| WO-2007055601-A1 | WOOD TREATMENT | STANIMIROFF IVAN LAURENCE (NZ) | 2007-05-18 | — | — | WO | disclosed |
| US-20050013939-A1 | Boron-based wood preservatives and treatment of wood with boron-based preservatives | THE UNIVERSITY OF MELBOURNE (AU) | 2005-01-20 | — | — | US | disclosed |
| WO-2002102560-A1 | BORON-BASED WOOD PRESERVATIVES AND TREATMENT OF WOOD WITH BORON-BASED PRESERVATIVES | THE UNIVERSITY OF MELBOURNE (AU) | 2002-12-27 | — | — | WO | disclosed |
| US-4281173-A | Preparation of unsaturated diesters by catalytic oxidative carbonylation of diolefins | ATLANTIC RICHFIELD COMPANY (US) | 1981-07-28 | — | — | US | disclosed |
| US-4195184-A | Preparation of unsaturated monoesters by catalytic oxidative carbonylation of diolefins | ATLANTIC RICHFIELD COMPANY (US) | 1980-03-25 | — | — | US | disclosed |
| US-4189599-A | Preparation of dimethyl adipate by the hydrogenation of dimethyl hex-3-endioate | ATLANTIC RICHFIELD COMPANY (US) | 1980-02-19 | — | — | US | disclosed |
| US-4171450-A | Preparation of unsaturated diesters by catalytic oxidative carbonylation of diolefins | ATLANTIC RICHFIELD COMPANY (US) | 1979-10-16 | — | — | US | disclosed |
| US-4041068-A | AS CATALYST A PALLADIUM, PLATINUM OR RHODIUM SALT WITH AN AMINE AND AN ALCOHOL | ATLANTIC RICHFIELD COMPANY (US) | 1977-08-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050013939-A1 | Boron-based wood preservatives and treatment of wood with boron-based preservatives | BTD, ADH1C, BROX | ALDH1A1 269/4885TDP1 1909/4885PRKCA 4498/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.